Dr Smith is a Biotech/Pharmaceutical Executive, Board Director and Clinical/Scientific Advisor in the US, Europe, Canada and Asia. Her breadth of experience covers over 100 clinical trials and 20+ major regulatory approvals in multiple jurisdictions, including FDA (USA), EMA (Europe), TGA (Australia), ANVISA (Brazil), and PMDA (Japan); leading to product launches across diverse therapeutic areas including areas in oncology, rare disease, cardiology, dermatology, neuroscience, and anti-infectives. In addition to R&D and pipeline development, Dr Smith’s successful record of business development includes acquisitions, divestitures, and partnership deals.